BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 15109961)

  • 1. Cathepsin L is crucial for a Th1-type immune response during Leishmania major infection.
    Onishi K; Li Y; Ishii K; Hisaeda H; Tang L; Duan X; Dainichi T; Maekawa Y; Katunuma N; Himeno K
    Microbes Infect; 2004 Apr; 6(5):468-74. PubMed ID: 15109961
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment with cathepsin L inhibitor potentiates Th2-type immune response in Leishmania major-infected BALB/c mice.
    Zhang T; Maekawa Y; Sakai T; Nakano Y; Ishii K; Hisaeda H; Dainichi T; Asao T; Katunuma N; Himeno K
    Int Immunol; 2001 Aug; 13(8):975-82. PubMed ID: 11470767
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Switch of CD4+ T cell differentiation from Th2 to Th1 by treatment with cathepsin B inhibitor in experimental leishmaniasis.
    Maekawa Y; Himeno K; Ishikawa H; Hisaeda H; Sakai T; Dainichi T; Asao T; Good RA; Katunuma N
    J Immunol; 1998 Sep; 161(5):2120-7. PubMed ID: 9725203
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pepstatin A-sensitive aspartic proteases in lysosome are involved in degradation of the invariant chain and antigen-processing in antigen presenting cells of mice infected with Leishmania major.
    Zhang T; Maekawa Y; Yasutomo K; Ishikawa H; Fawzy Nashed B; Dainichi T; Hisaeda H; Sakai T; Kasai M; Mizuochi T; Asao T; Katunuma N; Himeno K
    Biochem Biophys Res Commun; 2000 Sep; 276(2):693-701. PubMed ID: 11027533
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Leishmania major: a clone with low virulence for BALB/c mice elicits a Th1 type response and protects against infection with a highly virulent clone.
    Li J; Nolan TJ; Farrell JP
    Exp Parasitol; 1997 Sep; 87(1):47-57. PubMed ID: 9287957
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cathepsin B-inhibitor promotes the development of Th1 type protective T cells in mice infected with Leishmania major.
    Maekawa Y; Himeno K; Katunuma N
    J Med Invest; 1997 Aug; 44(1-2):33-9. PubMed ID: 9395715
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cathepsin B-Deficient Mice Resolve Leishmania major Inflammation Faster in a T Cell-Dependent Manner.
    Rasid O; Mériaux V; Khan EM; Borde C; Ciulean IS; Fitting C; Manoury B; Cavaillon JM; Doyen N
    PLoS Negl Trop Dis; 2016 May; 10(5):e0004716. PubMed ID: 27182703
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Distinct immunological states in murine cutaneous leishmaniasis by immunising with different amounts of antigen: the generation of beneficial, potentially harmful, harmful and potentially extremely harmful states.
    Bretscher PA; Ogunremi O; Menon JN
    Behring Inst Mitt; 1997 Feb; (98):153-9. PubMed ID: 9382736
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cathepsin B in antigen-presenting cells controls mediators of the Th1 immune response during Leishmania major infection.
    Gonzalez-Leal IJ; Röger B; Schwarz A; Schirmeister T; Reinheckel T; Lutz MB; Moll H
    PLoS Negl Trop Dis; 2014 Sep; 8(9):e3194. PubMed ID: 25255101
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pregnancy impairs resistance of C57BL/6 mice to Leishmania major infection and causes decreased antigen-specific IFN-gamma response and increased production of T helper 2 cytokines.
    Krishnan L; Guilbert LJ; Russell AS; Wegmann TG; Mosmann TR; Belosevic M
    J Immunol; 1996 Jan; 156(2):644-52. PubMed ID: 8543816
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The mechanism of in vitro T helper cell type 1 to T helper cell type 2 switching in highly polarized Leishmania major-specific T cell populations.
    Mocci S; Coffman RL
    J Immunol; 1997 Feb; 158(4):1559-64. PubMed ID: 9029090
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Susceptibility to Leishmania major infection in interleukin-4-deficient mice.
    Noben-Trauth N; Kropf P; Müller I
    Science; 1996 Feb; 271(5251):987-90. PubMed ID: 8584936
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Induction of a Th2 population from a polarized Leishmania-specific Th1 population by in vitro culture with IL-4.
    Mocci S; Coffman RL
    J Immunol; 1995 Apr; 154(8):3779-87. PubMed ID: 7706719
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vaccination with a plasmid DNA cocktail encoding the nucleosomal histones of Leishmania confers protection against murine cutaneous leishmaniosis.
    Iborra S; Soto M; Carrión J; Alonso C; Requena JM
    Vaccine; 2004 Sep; 22(29-30):3865-76. PubMed ID: 15364433
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Functional plasticity of the LACK-reactive Vbeta4-Valpha8 CD4(+) T cells normally producing the early IL-4 instructing Th2 cell development and susceptibility to Leishmania major in BALB / c mice.
    Maillard I; Launois P; Himmelrich H; Acha-Orbea H; Diggelmann H; Locksley RM; Louis JA
    Eur J Immunol; 2001 Apr; 31(4):1288-96. PubMed ID: 11298356
    [TBL] [Abstract][Full Text] [Related]  

  • 16. IL-4 instructs TH1 responses and resistance to Leishmania major in susceptible BALB/c mice.
    Biedermann T; Zimmermann S; Himmelrich H; Gumy A; Egeter O; Sakrauski AK; Seegmüller I; Voigt H; Launois P; Levine AD; Wagner H; Heeg K; Louis JA; Röcken M
    Nat Immunol; 2001 Nov; 2(11):1054-60. PubMed ID: 11600887
    [TBL] [Abstract][Full Text] [Related]  

  • 17. LeIF: a recombinant Leishmania protein that induces an IL-12-mediated Th1 cytokine profile.
    Skeiky YA; Kennedy M; Kaufman D; Borges MM; Guderian JA; Scholler JK; Ovendale PJ; Picha KS; Morrissey PJ; Grabstein KH; Campos-Neto A; Reed SG
    J Immunol; 1998 Dec; 161(11):6171-9. PubMed ID: 9834103
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel physiological functions of cathepsins B and L on antigen processing and osteoclastic bone resorption.
    Katunuma N; Matsunaga Y; Matsui A; Kakegawa H; Endo K; Inubushi T; Saibara T; Ohba Y; Kakiuchi T
    Adv Enzyme Regul; 1998; 38():235-51. PubMed ID: 9762356
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Different cytokines are required for induction and maintenance of the Th2 type response in DBA/2 mice resistant to infection with Leishmania major.
    Nashed BF; Maekawa Y; Takashima M; Zhang T; Ishii K; Dainichi T; Ishikawa H; Sakai T; Hisaeda H; Himeno K
    Microbes Infect; 2000 Oct; 2(12):1435-43. PubMed ID: 11099930
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The regulation of immunity to Leishmania major.
    Reiner SL; Locksley RM
    Annu Rev Immunol; 1995; 13():151-77. PubMed ID: 7612219
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.